Delivery Order SPE2DB20D3103-SPE2DB24FN2J9
- Not listed
- This federal contract award is for the delivery of Sandostatin LAR Depot 30 mg kits to the Defense Logistics Agency (DLA). The $30,995.42 firm fixed-price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on December 12, 2024, with a completion date of December 13, 2024. The contract has no set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
- This federal contract award is for the delivery of Sandostatin LAR Depot 10 mg kits, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The $16,250.77 firm fixed-price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This contract is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen's parent company, Cencora, Inc., holds with...
- This federal contract award is for the delivery of Sandostatin LAR Depot 30 mg kits to the Defense Logistics Agency (DLA). The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a firm fixed price of $8,813.00 and a completion date of December 13, 2024. AmerisourceBergen has an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November 2026, which serves...
- This federal contract award is for the delivery of Sandostatin LAR Depot 30 mg kits to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The $3,931.32 firm fixed-price contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a major pharmaceutical distribution company. The contract has an ultimate completion date of April 16, 2024. This delivery order contract is part of a larger Indefinite Delivery Contract...
- This federal contract award is for the delivery of Sandostatin LAR Depot 30 mg kits to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a fixed-price delivery order type with a ceiling value of $4,600.46 and an ultimate completion date of February 16, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of Sandostatin LAR Depot 30 mg kits, a pharmaceutical product. The contract has a ceiling value of $6,142.34 and is a firm-fixed-price delivery order with a completion date of May 29, 2025. The contract is not set aside for any particular business type. Amerisourcebergen Drug Corp holds a...
- The federal contract award is for the delivery of Sandostatin LAR Depot 10 mg kits, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The $7,415.74 firm fixed price delivery order was awarded to prime contractor Amerisourcebergen Drug Corp, Corporate Office Division, a major pharmaceutical distributor. This award is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 between Amerisourcebergen and DLA Troop Support Medical...
- This federal contract award is for the delivery of Sandostatin LAR Depot 30 mg kits to the Defense Logistics Agency (DLA) Troop Support Medical. The contract was awarded to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical sourcing and distribution services company. The award is a firm fixed price delivery order with a ceiling value of $3,914.52 and a performance period through March 18, 2024. Amerisourcebergen Drug Corp...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,496.96, is for the delivery of Sandostatin LAR Depot 30 mg medical kits. The contract has a completion date of April 2, 2024 and is a firm fixed-price delivery order. The award is not associated with any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a...
- The U.S. government's Defense Logistics Agency (DLA) awarded a delivery order contract worth $33,187.08 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a period of performance through March 18, 2025, is for the supply of Sandostatin LAR Depot 30 mg kits, a specialty medication used in the treatment of various medical conditions. This contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB24FN2J9Delivery Order
This federal contract award is for the delivery of Sandostatin LAR Depot 30 mg kits to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $7,496.96 and an ultimate completion date of April 2, 2024. It is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC, valued at up to $999,999,999.00, serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.5k | 4/1/24 |